Trump's trade deal with EU
Digest more
The U.N.'s World Food Programme has said that almost 470,000 people in Gaza are enduring famine-like conditions, with 90,000 women and children in need of specialist nutrition treatments. The Israeli government has rejected international criticism of its policies in the enclave.
Pharma firms are calling for clarity on tariffs imposed under the new U.S.-EU trade agreement, as analysts warn that punitive sector-specific levies could risk blowing up the entire deal. Ambiguity abounds around the terms for pharmaceutical goods under the trade truce agreed Sunday, which imposes 15% tariffs on EU goods imported to the U.S.
EU antitrust regulators have extended their decision deadline on a $775-million bid by Universal Music Group unit Virgin Music Group for Downtown Music to December 10, after Universal asked for more time,
The European Union plans to reduce a major package of financial support to Ukraine by €1.5 billion ($1.7 billion) after Kyiv said it had been unable to meet all required reform milestones, said a spokesperson of the bloc’s executive.
U.S. President Donald Trump and European Commission President Ursula von der Leyen have announced a sweeping trade deal. It raises tariffs on most European goods to 15%.
Explore more
Italy will tell the European Union the terms it imposed on UniCredit's bid for Banco BPM remain in place even after the collapse of the deal, sources said, responding to criticism from Brussels that could ultimately lead to disciplinary steps.
(Reuters) -The European Union's trade deal with the United States could cost the pharmaceutical industry between $13 billion and $19 billion as branded medicines become subject to a tariff of 15%, analysts said on Monday.
U.S. President Donald Trump and European Commission President Ursula von der Leyen have announced a sweeping trade deal that imposes 15% tariffs on most European goods, warding off Trump's threat of a 30% rate if no deal had been reached by Aug.
Commerce Secretary Howard Lutnick cast many of the issues surrounding the US-European Union trade pact as still up for discussion, saying there was “plenty of horse trading left to do.”